Protagonist Therapeutics (PTGX) Revenue (2017 - 2026)
Protagonist Therapeutics' Revenue was $213.48 million in Q2 2026, compared with $5.55 million a year earlier and up 278.7% from the prior quarter.
Powered by 
Analysis
Protagonist Therapeutics (PTGX) Revenue (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Protagonist Therapeutics' Revenue was $281.99 million through Jun 30, 2026, up 34.8% year-over-year; for FY2025, it was $46.02 million, down 89.4% from FY2024.
- Revenue shows a five-year compound annual growth rate of 10.0% (FY2020 to FY2025).
- In earlier years, Revenue was $434.43 million in FY2024 (+624.1%), $60 million in FY2023 (+125.7%), $26.58 million in FY2022 (-2.8%) and $27.36 million in FY2021 (-4.4%).
- The Q2 2026 figure marks the highest quarterly Revenue since Q1 2024.
- Compared with a year earlier, Revenue was higher in four of the last six quarters, with growth averaging 22.1%.
- The best year-over-year quarter for Revenue over five years was Q1 2022 (growth of 315.6%); the worst was Q4 2025 (a decline of 95.6%).
- Per Business Quant data, PTGX's Revenue in the three quarters before Q2 2026 was $56.37 million (Q1 2026), $7.44 million (Q4 2025) and $4.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Protagonist Therapeutics | 9.21 Bn | 9.21 Bn | - | 213.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 213.48 Mn |
| Mar 31, 2026 | 56.37 Mn |
| Dec 31, 2025 | 7.44 Mn |
| Sep 30, 2025 | 4.71 Mn |
| Jun 30, 2025 | 5.55 Mn |
| Mar 31, 2025 | 28.32 Mn |
| Dec 31, 2024 | 170.64 Mn |
| Sep 30, 2024 | 4.68 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | 254.95 Mn |
| Dec 31, 2023 | 60.00 Mn |
| Dec 31, 2022 | -19,000.00 |
| Jun 30, 2022 | 900,000.00 |
| Mar 31, 2022 | 25.72 Mn |
| Dec 31, 2021 | 8.62 Mn |
| Sep 30, 2021 | 10.29 Mn |
| Jun 30, 2021 | 2.27 Mn |
| Mar 31, 2021 | 6.19 Mn |
| Dec 31, 2020 | 5.65 Mn |
| Sep 30, 2020 | 13.11 Mn |
API Access
Protagonist Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=PTGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "PTGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=PTGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();